Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)

被引:102
|
作者
Thode, Adam R. [1 ]
Latkany, Robert A. [1 ]
机构
[1] New York Eye & Ear Infirm Mt Sinai, New York, NY 10003 USA
关键词
POLYUNSATURATED FATTY-ACIDS; DRY EYE; LIPID LAYER; DIETARY SUPPLEMENTATION; AZITHROMYCIN; EFFICACY; CLASSIFICATION; 0.05-PERCENT; MINOCYCLINE; CYTOKINES;
D O I
10.1007/s40265-015-0432-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow (R). While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N-acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.
引用
收藏
页码:1177 / 1185
页数:9
相关论文
共 50 条
  • [1] Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)
    Adam R. Thode
    Robert A. Latkany
    Drugs, 2015, 75 : 1177 - 1185
  • [2] Hyaluronan prevents Meibomian Gland Dysfunction (MGD)
    Sun, Mingxia
    Moreno, Isabel
    Gesteira, Tarsis F.
    Coulson-Thomas, Vivien J.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2022, 103 (06) : A3 - A3
  • [3] Keratinization of the Human Meibomian Gland and Its Contribution to Meibomian Gland Dysfunction (mgd)
    Knop, E.
    Ludescher, M.
    Knop, N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [4] Therapeutic Effect of Intense Pulsed Light (IPL) Combined with Meibomian Gland Expression (MGX) on Meibomian Gland Dysfunction (MGD)
    Wei, Shanshan
    Ren, Xiaotong
    Wang, Yuexin
    Chou, Yilin
    Li, Xuemin
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [5] Emerging treatment options for meibomian gland dysfunction
    Qiao, Jing
    Yan, Xiaoming
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1797 - 1802
  • [6] Treatment of Meibomian Gland Dysfunction (MGD) With the Novel LipiFlow® Thermal Pulsation System Restores Meibomian Gland Function
    Greiner, J. V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [7] The role of intense pulsed light (IPL) in the treatment of meibomian gland dysfunction (MGD)
    Tenna Stefania
    Turco Piergiorgio
    Brunetti Beniamino
    Antonio Di Zazzo
    Macchi Jacopo
    Bonini Stefano
    Persichetti Paolo
    European Journal of Plastic Surgery, 2019, 42 : 563 - 568
  • [8] The role of intense pulsed light (IPL) in the treatment of meibomian gland dysfunction (MGD)
    Stefania, Tenna
    Piergiorgio, Turco
    Beniamino, Brunetti
    Di Zazzo, Antonio
    Jacopo, Macchi
    Stefano, Bonini
    Paolo, Persichetti
    EUROPEAN JOURNAL OF PLASTIC SURGERY, 2019, 42 (06) : 563 - 568
  • [9] Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting
    Geerling, Gerd
    Baudouin, Christophe
    Aragona, Pasquale
    Rolando, Maurizio
    Boboridis, Kostas G.
    Benitez-del-Castillo, Jose M.
    Akova, Yonca A.
    Merayo-Lloves, Jesus
    Labetoulle, Marc
    Steinhoff, Martin
    Messmer, Elisabeth M.
    OCULAR SURFACE, 2017, 15 (02): : 179 - 192
  • [10] Changes in the Meibomian Gland After Exposure to Intense Pulsed Light in Meibomian Gland Dysfunction (MGD) Patients
    Yin, Yue
    Liu, Ninghua
    Gong, Lan
    Song, Nan
    CURRENT EYE RESEARCH, 2018, 43 (03) : 308 - 313